Skip to main content
. 2021 Aug 28;47:179. doi: 10.1186/s13052-021-01130-4

Table 8.

Proposed switch to oral therapy on the basis of intravenous therapy

Intravenous therapy Proposed oral therapy
Cefazolin Cephalexin
Amoxicillin-clavulanate Amoxicillin-clavulanate
Ampicillin Amoxicillin
Ampicillin-sulbactam Amoxicillin-clavulanate
Oxacillin

Flucloxacillin

OR

Cephalexina

Clindamycin

Clindamycin

OR

Trimethoprim/sulfamethoxazolea

Ceftriaxone Amoxicillin-clavulanate

Ceftriaxone

+

Clindamycin or glycopeptides

Trimethoprim/sulfamethoxazole + Rifampicin
Vancomycin

Trimethoprim/sulfamethoxazole + Rifampicin

OR

Linezolidb

aIf ingestion of tablets is difficult/compromised

bNot registered for pediatric use